載入...
Bactericidal Activity and Resistance Development Profiling of Dalbavancin
Dalbavancin, a semisynthetic lipoglycopeptide being developed for the treatment of skin and skin structure infections (SSSIs), has a half-life of 5 to 7 days in humans and offers promise for a convenient weekly dosing regimen. We studied the in vitro bactericidal activity of dalbavancin against targ...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology
2007
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1855483/ https://ncbi.nlm.nih.gov/pubmed/17220411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00620-06 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|